Resonance Specialties Limited (BOM:524218)

India · Delayed Price · Currency is INR

197.05

+6.10 (3.19%)

At close: Oct 1, 2026

Market Cap	2.27B +98.0%
Revenue (ttm)	1.02B +24.2%
Net Income	145.10M +90.7%
EPS	12.58 +91.0%
Shares Out	11.54M
PE Ratio	15.67
Forward PE	n/a
Dividend	1.00 (0.51%)
Ex-Dividend Date	Jul 28, 2026

Volume	23,212
Open	190.95
Previous Close	190.95
Day's Range	183.00 - 200.00
52-Week Range	77.00 - 201.30
Beta	0.58
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 30, 2026

About Resonance Specialties

Resonance Specialties Limited engages in the manufacture and marketing of specialty chemicals in India and internationally. It offers pyridine, a chemical used in agrochemicals, pharmaceuticals, latexes, food, and allied industries, as well as to manufacture vitamins, medicines, food flavoring, dyes, adhesives, pesticides, herbicides, etc.; and picolines, including beta and gamma picolines used in manufacturing vinyl latex rubber, vitamin B3, and anti-tuberculosis drugs. The company also provides nutritional drug products, such as zinc and chro... [Read more]

Industry Medicinal Chemicals and Botanical Products

Founded 1989

Employees 74

Stock Exchange Bombay Stock Exchange

Ticker Symbol 524218

Full Company Profile

Financial Performance

In fiscal year 2026, Resonance Specialties's revenue was 902.48 million, an increase of 15.99% compared to the previous year's 778.07 million. Earnings were 103.96 million, an increase of 58.32%.

Financial Statements